Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Positive Vasculitis and Agranulocytosis: A Rare Case with Life-Threatening Multiple Systemic Manifestations.

Propylthiouracil-Induced Vasculitis With Alveolar Hemorrhage Confirmed by Clinical, Laboratory, Computed Tomography, and Bronchoscopy Findings: A Case Report and Literature Review.

Propylthiouracil-induced alveolar hemorrhage.

Propylthiouracil-induced autoimmune disease.

Propylthiouracil induced pulmonary-renal syndrome: a case report.

A 27-year-old woman presenting with refractory hypoxaemic respiratory failure, haemoptysis and thyrotoxicosis: a rare manifestation of propylthiouracil therapy.

Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.

Occult pulmonary hemorrhage as a rare presentation of propylthiouracil-induced vasculitis.

[Diffuse alveolar hemorrhage: Causes and outcomes in a referral center].

Propylthiouracil-induced leucocytoclastic vasculitis with pulmonary hemorrhage treated with plasmapheresis.

Thionamide-induced vasculitis: a case of alveolar haemorrhage secondary to propylthiouracil.

Propylthiouracil-related diffuse alveolar hemorrhage with negative serologies and without capillaritis.

A fatal case of propylthiouracil-induced ANCA-positive vasculitis.

Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).

Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment.

Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil.

Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease.

Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure.